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This Article contains an error in the order of the Figures. Figures 2, 3, 4 and 5 were published as Figures 4, 2, 5 and 3 respectively. The correct Figures [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"} appear below. The Figure legends are correct.Figure 2Examples of \[1-^13^C\]-acetate uptake in the aorta and kidneys over time. Hyperpolarized \[1-^13^C\]-acetate signal overlaid ^1^H-anatomical MR images of an axial slice, showing two kidneys and the presence of a signal in the aorta and following the kidneys. MR; magnetic resonance.Figure 3^13^C-acetate *in vivo* hemodynamic parameters. Acetate perfusion (min/100 ml/mL), mean transit time (MTT) (sec), and acetate mean transit time metabolic clearance rate *K*~*MTT*~ (min^−1^) before and after administration of furosemide. The mean is plotted with standard errors.Figure 4Examples of ^11^C-acetate uptake in the aorta and kidneys over time. Positron emission tomography ^11^C-acetate signal overlaid 1H-anatomical MR images of a coronal slice, showing two kidneys and the presence of a signal in the aorta and following the kidneys. MR; magnetic resonance.Figure 5^11^C-acetate *in vivo* kinetic parameters. (**A**) ^11^C-acetate single exponential metabolic clearance rate, K~mono~. (**B**) ^11^C-acetate mean transit time metabolic clearance rate, *K*~*MTT*~. (**C**) Correlations between the decay derived or the first moment derived rates and the hyperpolarized ^13^C, showing a positive correlation (R^2^ = 0.82, *P* = 0.0003). (**D**) A tendency towards a similar response to furosemide treatment is seen between the ^11^C-PET and the ^13^C-hyperpolarization estimations. The mean is plotted with standard errors. PET, positron emission tomography.
